Q3 2021 Holdings
Filed 2021-11-12 | 172 holdings | $336.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $66.2M | 233,853 | 19.7% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $56.5M | 524,213 | 16.8% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $35.8M | 189,695 | 10.6% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $32.4M | 78,484 | 9.6% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $23.1M | 63,772 | 6.9% |
| BioNTech SE(BNTX) | Sponsored ADS | 09075V102 | $22.0M | 80,757 | 6.6% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $12.7M | 204,214 | 3.8% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $11.6M | 38,456 | 3.5% |
| Adaptive Biotechnologies Corp.(ADPT) | Common | 00650F109 | $11.5M | 337,722 | 3.4% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $10.8M | 67,794 | 3.2% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $9.9M | 128,004 | 2.9% |
| Boston Scientific Corp.(BSX) | Common | 101137107 | $8.1M | 185,931 | 2.4% |
| Arvinas, Inc.(ARVN) | Common | 04335A105 | $7.1M | 85,997 | 2.1% |
| Addus HomeCare Corp.(ADUS) | Common | 006739106 | $6.7M | 83,632 | 2.0% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $5.6M | 252,821 | 1.7% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $5.0M | 7,459 | 1.5% |
| Arcutis Biotherapeutics, Inc.(ARQT) | Common | 03969K108 | $3.1M | 131,633 | 0.9% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $1.9M | 80,448 | 0.6% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $1.2M | 101,535 | 0.4% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $1.1M | 131,990 | 0.3% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $712.0K | 539,408 | 0.2% |
| ALX Oncology Holdings Inc.(ALXO) | Common | 00166B105 | $524.0K | 7,099 | 0.2% |
| Moderna, Inc.(MRNA) | Common | 60770K107 | $176.8K | 459,456 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $122.3K | 574,918 | 0.0% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $119.6K | 306,129 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $119.3K | 1,708,065 | 0.0% |
| Horizon Therapeutics plc | Shares | G46188101 | $99.7K | 910,340 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $89.6K | 148,015 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $83.5K | 146,116 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $83.4K | 516,652 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $78.7K | 193,963 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $77.6K | 657,038 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $75.3K | 600,722 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $63.6K | 275,432 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $61.3K | 816,305 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $49.5K | 79,663 | 0.0% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $49.5K | 273,046 | 0.0% |
| AstraZeneca plc(AZN) | Sponsored ADR | 046353108 | $48.8K | 812,927 | 0.0% |
| Guardant Health, Inc.(GH) | Common | 40131M109 | $48.5K | 387,984 | 0.0% |
| Danaher Corp.(DHR) | Common | 235851102 | $45.3K | 148,683 | 0.0% |
| Cigna Corp.(CI) | Common | 125523100 | $44.4K | 221,740 | 0.0% |
| Stryker Corp.(SYK) | Common | 863667101 | $39.7K | 150,500 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $39.4K | 426,514 | 0.0% |
| Rallybio Corp. | Common | 75120L100 | $37.6K | 2,308,672 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $36.2K | 612,236 | 0.0% |
| McKesson Corp.(MCK) | Common | 58155Q103 | $36.2K | 181,577 | 0.0% |
| Seagen Inc.(SGENUSD) | Common | 81181C104 | $35.2K | 207,334 | 0.0% |
| Zimmer Biomet Holdings, Inc.(ZBH) | Common | 98956P102 | $32.6K | 222,703 | 0.0% |
| Novavax, Inc.(NVAX) | Common | 670002401 | $31.4K | 151,491 | 0.0% |
| Zoetis Inc.(ZTS) | Class A | 98978V103 | $27.7K | 142,597 | 0.0% |